# FemPulse Therapy First-in-Human Experience

> **NCT03874637** · NA · COMPLETED · sponsor: **FemPulse Corporation** · enrollment: 15 (actual)

## Conditions studied

- Urinary Bladder, Overactive

## Interventions

- **DEVICE:** Treament
- **DEVICE:** Sham Control

## Key facts

- **NCT ID:** NCT03874637
- **Lead sponsor:** FemPulse Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-14
- **Primary completion:** 2017-05-17
- **Final completion:** 2017-05-17
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03874637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03874637, "FemPulse Therapy First-in-Human Experience". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03874637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*